FI861069L - Antivirala nukleosider. - Google Patents

Antivirala nukleosider. Download PDF

Info

Publication number
FI861069L
FI861069L FI861069A FI861069A FI861069L FI 861069 L FI861069 L FI 861069L FI 861069 A FI861069 A FI 861069A FI 861069 A FI861069 A FI 861069A FI 861069 L FI861069 L FI 861069L
Authority
FI
Finland
Prior art keywords
nucleosider
antiviral
antiviral nucleosider
Prior art date
Application number
FI861069A
Other languages
English (en)
Other versions
FI861069A0 (fi
FI85978B (fi
FI85978C (fi
Inventor
Janet Rideout
David Walter Barry
Sandra Nusinoff Lehrman
Clair Martha Heider St
Phillip Allen Furman
George Andrew Freeman
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27516579&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI861069(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB858506869A external-priority patent/GB8506869D0/en
Priority claimed from GB858511774A external-priority patent/GB8511774D0/en
Priority claimed from US06/776,899 external-priority patent/US4724232A/en
Priority claimed from GB858523881A external-priority patent/GB8523881D0/en
Priority claimed from GB868603450A external-priority patent/GB8603450D0/en
Publication of FI861069A0 publication Critical patent/FI861069A0/fi
Application filed by Wellcome Found filed Critical Wellcome Found
Priority to FI902941A priority Critical patent/FI902941A7/fi
Publication of FI861069L publication Critical patent/FI861069L/fi
Publication of FI85978B publication Critical patent/FI85978B/fi
Publication of FI85978C publication Critical patent/FI85978C/fi
Application granted granted Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI861069A 1985-03-16 1986-03-14 Foerfarande foer framstaellning av ett terapeutiskt anvaendbart salt eller ester av 3'-azido-3'deoxitymidin. FI85978C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI902941A FI902941A7 (fi) 1985-03-16 1986-03-14 Menetelmä faramaseuttisen valmisteen valmistamiseksi

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB858506869A GB8506869D0 (en) 1985-03-16 1985-03-16 Antiviral compound
GB8506869 1985-03-16
GB858511774A GB8511774D0 (en) 1985-05-09 1985-05-09 Antiviral compounds
GB8511774 1985-05-09
US06/776,899 US4724232A (en) 1985-03-16 1985-09-17 Treatment of human viral infections
US77689985 1985-09-17
GB858523881A GB8523881D0 (en) 1985-09-27 1985-09-27 Antiviral compounds
GB8523881 1985-09-27
GB868603450A GB8603450D0 (en) 1986-02-12 1986-02-12 Antiviral compounds
GB8603450 1986-02-12

Publications (4)

Publication Number Publication Date
FI861069A0 FI861069A0 (fi) 1986-03-14
FI861069L true FI861069L (fi) 1986-09-17
FI85978B FI85978B (fi) 1992-03-13
FI85978C FI85978C (fi) 1992-06-25

Family

ID=27516579

Family Applications (1)

Application Number Title Priority Date Filing Date
FI861069A FI85978C (fi) 1985-03-16 1986-03-14 Foerfarande foer framstaellning av ett terapeutiskt anvaendbart salt eller ester av 3'-azido-3'deoxitymidin.

Country Status (21)

Country Link
EP (2) EP0291633B1 (fi)
JP (1) JPH0780898B2 (fi)
AP (1) AP11A (fi)
AT (4) ATE81978T1 (fi)
AU (1) AU572019B2 (fi)
CA (1) CA1238277A (fi)
CS (1) CS385191A3 (fi)
CY (2) CY1508A (fi)
DE (4) DE3650130T3 (fi)
DK (1) DK164392C (fi)
FI (1) FI85978C (fi)
GR (1) GR860712B (fi)
HK (2) HK85789A (fi)
IE (1) IE56503B1 (fi)
IL (1) IL78158A (fi)
MC (1) MC1742A1 (fi)
MY (1) MY102693A (fi)
NZ (1) NZ215486A (fi)
PH (1) PH24388A (fi)
PT (1) PT82199B (fi)
SG (1) SG62889G (fi)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU595832B2 (en) * 1985-09-17 1990-04-12 Wellcome Foundation Limited, The Therapeutic nucleosides
US4841039A (en) * 1986-05-01 1989-06-20 Emory University 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
US5084445A (en) * 1986-05-01 1992-01-28 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine
US4916122A (en) * 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
US5077279A (en) * 1986-05-01 1991-12-31 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
WO1988003804A2 (en) * 1986-11-21 1988-06-02 Max-Planck-Gesellschaft Zur Förderung Der Wissensc Method of treating viral infections in humans and compositions therefor
US4880782A (en) * 1986-11-21 1989-11-14 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. Method of treating viral infections in humans and compositions therefor
SE8605503D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel medicinal use
US5190926A (en) * 1987-01-28 1993-03-02 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents
PT86982B (pt) * 1987-03-16 1992-06-30 Wellcome Found Processo para a preparacao de nucleosidos
EP0282618A1 (en) * 1987-03-18 1988-09-21 Vereniging Het Nederlands Kanker Instituut 1-Deoxynojirimycin as an anti-HIV therapeutic
EP0286825A3 (en) * 1987-03-18 1989-04-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Use of 3'-fluro-3' deoxythymidine for the manufacture of a medicament for the treatment of virus infections
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
KR880011146A (ko) * 1987-03-25 1988-10-26 엠.피.젝슨 3'-아지도-3'-디옥시티미딘의 신규 제조방법 및 이러한 공정에 유용한 중간체
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US5185437A (en) * 1987-04-09 1993-02-09 Burroughs Wellcome Co. Therapeutic nucleosides
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
IL86009A (en) * 1987-04-10 1991-09-16 Us Health Liposome-encapsulated phosphorylated nucleosides for treatment of retroviral diseases
US5215970A (en) * 1987-04-16 1993-06-01 Medivir Ab Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
SE8701605D0 (sv) * 1987-04-16 1987-04-16 Astra Ab Novel medicinal compounds
DE3868125D1 (de) * 1987-04-24 1992-03-12 Wellcome Found Antivirale mischungen.
US4863927A (en) * 1987-05-11 1989-09-05 Merck & Co., Inc. 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils
YU110888A (en) * 1987-06-10 1989-08-31 Wellcome Found Process for obtaining timine derivatives
USRE33887E (en) * 1987-06-22 1992-04-14 Hoffmann-La Roche Inc. Anti-retroviral compounds
SU1548182A1 (ru) * 1987-12-29 1990-03-07 Институт молекулярной биологии АН СССР 5 @ -Фосфонаты 3 @ -азидо-2 @ ,3 @ -дидезоксинуклеозидов, вл ющиес специфическими ингибиторами вируса СПИД в культуре лимфоцитов человека Н9/ШВ
US5384396A (en) * 1988-02-23 1995-01-24 The University Of Georgia Research Foundation, Inc. Process for the deoxygenation of nucleosides
DE3824669C2 (de) * 1988-07-20 1999-05-06 Wondrak Ewald M Verwendung von Trinatrium-Phosphonoformat
US4987224A (en) * 1988-08-02 1991-01-22 University Of Georgia Research Foundation, Inc. Method of preparation of 2',3'-dideoxynucleosides
EP0355245A1 (fr) * 1988-08-26 1990-02-28 Michel Vandevelde Utilisation d'agents d'inhibition de la réverse-transcriptase des rétrovirus
HU205089B (en) * 1989-05-31 1992-03-30 Biogal Gyogyszergyar Process for producing new thymine derivatives and pharmaceutical compositions comprising same
EP0427246B1 (de) * 1989-11-09 1995-08-09 ASTA Medica Aktiengesellschaft Arzneimittel, welche als Wirkstoff Schwefel enthaltende Carbonsäuren enthalten sowie deren Verwendung zur Bekämpfung von Retroviren
US5585367A (en) * 1990-04-19 1996-12-17 Previsan S.A. Method of treating humans and animals infected with viruses of the retrovirus group
ES2060373T3 (es) * 1990-04-19 1994-11-16 Previsan Sa Derivados azoicos, compuestos farmaceuticos y desinfectantes que los contienen y su utilizacion contra el sida.
US6812233B1 (en) 1991-03-06 2004-11-02 Emory University Therapeutic nucleosides
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
IL102548A (en) * 1991-08-02 1998-08-16 Medivir Ab Thiourea derivatives for use in the preparation of medicaments for the inhibition of hiv and the treatment of aids and some such novel compounds
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses
ATE184787T1 (de) * 1992-05-13 1999-10-15 Wellcome Found Therapeutische kombinationen
US6177435B1 (en) 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
GR920100326A (el) * 1992-07-21 1994-03-31 Medivir Ag Ενώσεις και μέ?οδοι αναστολής του HIV και των σχετικών ιών.
DE4336640A1 (de) * 1993-10-22 1995-04-27 Deutsches Rheuma Forschungszen Neue Metallchelate, Verfahren zu deren Herstellung sowie deren Verwendung als antivirale Arzneimittel
CA2270600A1 (en) 1999-05-03 2000-11-03 Infectio Recherche Inc. Method and formulations for the treatment of diseases, particularly those caused by human immunodeficiency virus and leishmania
US7169780B2 (en) 2001-10-26 2007-01-30 Istitute Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
EP1490090A4 (en) 2002-02-22 2006-09-20 New River Pharmaceuticals Inc SYSTEMS FOR DELIVERING ACTIVE AGENTS AND METHODS FOR PROTECTING AND DELIVERING ACTIVE AGENTS
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
HUE072591T2 (hu) 2013-07-19 2025-11-28 Boehringer Ingelheim Vetmedica Gmbh Tartósított, éterezett ciklodextrinszármazékokat tartalmazó folyékony, vizes gyógyászati készítmény
WO2022008025A1 (en) * 2020-07-05 2022-01-13 Since & Technology Development Fund Authority 2-hydroxyiminopyrimidine nucleosides and derivitives and antiviral uses thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK166805B1 (da) * 1985-03-16 1993-07-19 Wellcome Found Threo-isomeren af 3'-azido-3'-deoxythymidin til anvendelse ved behandling af eller profylakse for humane retrovirusinfektioner, anvendelse af forbindelsen til fremstilling af et laegemiddel med naevnte indikation og farmaceutisk praeparat indeholdende forbindelsen

Also Published As

Publication number Publication date
AT390000B (de) 1990-02-26
NZ215486A (en) 1988-09-29
DE196185T1 (de) 1987-04-30
DE3650130D1 (de) 1994-12-08
DE3650130T2 (de) 1995-03-16
DE3650130T3 (de) 2003-07-24
GR860712B (en) 1986-07-16
SG62889G (en) 1990-01-26
MC1742A1 (fr) 1987-02-26
EP0196185A2 (en) 1986-10-01
ATE81978T1 (de) 1992-11-15
EP0291633A1 (en) 1988-11-23
FI861069A0 (fi) 1986-03-14
AU5475886A (en) 1986-09-18
DK164392C (da) 1992-11-09
EP0196185A3 (en) 1988-01-13
JPH0780898B2 (ja) 1995-08-30
DK118086A (da) 1986-09-17
ATE113603T1 (de) 1994-11-15
EP0291633B1 (en) 1992-11-04
DK164392B (da) 1992-06-22
MY102693A (en) 1992-09-30
FI85978B (fi) 1992-03-13
DE3608606A1 (de) 1986-09-18
CY1508A (en) 1990-08-03
DE3687069T2 (de) 1993-03-25
ATE44464T1 (de) 1989-07-15
JPS63290895A (ja) 1988-11-28
HK164395A (en) 1995-10-27
HK85789A (en) 1989-11-03
DE3687069D1 (de) 1992-12-10
PH24388A (en) 1990-06-13
PT82199B (pt) 1990-11-07
AP8600027A0 (en) 1986-02-01
EP0196185B1 (en) 1989-07-12
AP11A (en) 1987-12-22
FI85978C (fi) 1992-06-25
DK118086D0 (da) 1986-03-14
CA1238277A (en) 1988-06-21
ATA68386A (de) 1989-08-15
IL78158A0 (en) 1986-07-31
IE860677L (en) 1986-09-16
AU572019B2 (en) 1988-04-28
IL78158A (en) 1988-04-29
PT82199A (en) 1986-04-01
IE56503B1 (en) 1991-08-14
CS385191A3 (en) 1992-05-13
CY1889A (en) 1996-11-22

Similar Documents

Publication Publication Date Title
FI861069L (fi) Antivirala nukleosider.
FI861822A7 (fi) Antivirala kompositioner.
DE3687397D1 (de) 2-fluorarabinofuranosylpurinnukleoside.
DE3681208D1 (de) Fluormeter.
DE3685608D1 (de) 8-phenylxanthine.
DE3685611D1 (de) Polysiloxanelastomer.
ATE55980T1 (de) 2-hydroxy-3-phenoxypropylamine.
DE3668381D1 (de) Contactlinse.
DE3668885D1 (de) Fluorbenzylester.
DE3687867D1 (de) Mikrorechner.
FI870377L (fi) Antivirala kompositioner.
FI83377B (fi) Mikrovaogsugn.
DE3673520D1 (de) Perfluorpolyaether.
FI80864B (fi) Roerlig elevatortransportoer.
DE3678182D1 (de) Perfluorpolycycloalkane.
DE3677472D1 (de) Blockierverhinderer.
DE3680606D1 (de) Loetapparat.
DE3683724D1 (de) Zahnstutz.
FI863783L (fi) Nytt framstaellningsfoerfarande foer vaermebestaendig transglukosidas.
DE3670979D1 (de) Raederfalzapparat.
FI73923B (fi) Polyamidhaltig maongskiktsfilm.
EP0217961A4 (en) Miticide.
DE3670767D1 (de) Rioprostil-pvp-komplex.
DE3667938D1 (de) Raederfalzapparat.
DE3670589D1 (de) Sandstrahlgeraet.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: THE WELLCOME FOUNDATION LIMITED

MA Patent expired